Cisa RSV infants study (lead site)
Active Awarded Last action
- Contract number
- 75D30124F00003
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $1,532,778
Award facts
- Opportunity
-
- 75D30124R73101 Solicitation number
- Contract value 99% obligated
-
- $1,532,777.65 Current, with exercised options
- $1,541,816.17 Potential, with all options
- Completion date 70% complete
- Current and potential, with all options
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,532,778 |
About this award
The Centers for Disease Control and Prevention (CDC Pittsburgh) issued a delivery order to Duke University on September 27, 2024, under the Clinical Immunization Safety Assessment 2023–2028 (CISA) IDIQ with a ceiling value of $1,541,816.17 for the CISA RSV Infants Study (Lead Site).
The CISA IDIQ supports clinical immunization safety assessment and related research activities across federal agencies. Place of performance is Durham, North Carolina. The order carries a cost-no-fee pricing structure with a completion date of September 26, 2027.
In fiscal year 2025, the order generated $285 thousand in invoiced labor supported by 1.3 FTEs, which Duke University self-performed without subcontractor engagement.
Quick answers
Who was awarded contract 75D30124F00003?
75D30124F00003 was awarded to Duke University by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 27, 2024.
How much is contract 75D30124F00003 worth?
The government has obligated $1,532,778 on 75D30124F00003. Its potential value, with all options, is $1,541,816.
Is contract 75D30124F00003 an order under another contract?
Yes. 75D30124F00003 is a delivery order under 75D30123D18241, an indefinite delivery contract, on Clinical Immunization Safety Assessment 2023 - 2028 (CISA).
Was contract 75D30124F00003 competed?
The extent of competition for 75D30124F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award